Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors.
Oncologist
; 24(8): 1128-1136, 2019 08.
Article
in En
| MEDLINE
| ID: mdl-31015312
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Monitoring
/
Carcinoma, Non-Small-Cell Lung
/
Drug-Related Side Effects and Adverse Reactions
/
Antineoplastic Agents, Immunological
/
Lung Neoplasms
/
Neutrophils
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2019
Type:
Article
Affiliation country:
Italy